본문바로가기
Q
U
I
C
K

Global Innovative Partner of Vaccine and Biotech SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

Our Science & Technology

Conducting research into vaccines that will be the driving force in the life science business going forward.

The world's best vaccine factory with advanced vaccine technology.

Leading in expanding the global market through cooperation with global companies.

What’s New

  • SK bioscience News SK bioscience Announces Start of RS...

    Administration begins for infants under 12 months, expected to provide protection throughout the RSV...

    More
  • News SK bioscience Launches Influen...

    Vaccination available for all age groups from Octo...

    More
  • News SK bioscience Submits IND for ...

    Approximately 800 children aged 12 months to 12 ye...

    More
  • News SK bioscience Successfully Con...

    Nationwide symposiums over two months enhanced RSV...

    More
  • News SK Group Chairman Taewon Chey ...

    SK Group Chairman Tae-won Chey met with Bill Gat...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products





PRODUCTS

SKYCellflu® Quadrivalent

SKYCellflu® Quadrivalent

[13494] 310, Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
Company Registration Number 818-86-00991

Copyright(c) SK bioscience. All Right Reserved

접근성 마크
  GO